255 related articles for article (PubMed ID: 25552692)
1. Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels.
Ballou LM; Lin RZ; Cohen IS
Circ Res; 2015 Jan; 116(1):127-37. PubMed ID: 25552692
[TBL] [Abstract][Full Text] [Related]
2. Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome.
Lu Z; Wu CY; Jiang YP; Ballou LM; Clausen C; Cohen IS; Lin RZ
Sci Transl Med; 2012 Apr; 4(131):131ra50. PubMed ID: 22539774
[TBL] [Abstract][Full Text] [Related]
3. Acquired long QT syndrome and phosphoinositide 3-kinase.
Cohen IS; Lin RZ; Ballou LM
Trends Cardiovasc Med; 2017 Oct; 27(7):451-459. PubMed ID: 28687226
[TBL] [Abstract][Full Text] [Related]
4. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current.
Yang T; Chun YW; Stroud DM; Mosley JD; Knollmann BC; Hong C; Roden DM
Circulation; 2014 Jul; 130(3):224-34. PubMed ID: 24895457
[TBL] [Abstract][Full Text] [Related]
5. Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart.
Lu Z; Jiang YP; Wu CY; Ballou LM; Liu S; Carpenter ES; Rosen MR; Cohen IS; Lin RZ
Diabetes; 2013 Dec; 62(12):4257-65. PubMed ID: 23974924
[TBL] [Abstract][Full Text] [Related]
6. Cardiac ion channels in health and disease.
Amin AS; Tan HL; Wilde AA
Heart Rhythm; 2010 Jan; 7(1):117-26. PubMed ID: 19875343
[TBL] [Abstract][Full Text] [Related]
7. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
Vincent GM
Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
[TBL] [Abstract][Full Text] [Related]
9. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
10. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
11. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.
Antzelevitch C
Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323
[TBL] [Abstract][Full Text] [Related]
12. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.
Varró A; Papp JG
Cardioscience; 1992 Sep; 3(3):131-44. PubMed ID: 1384746
[TBL] [Abstract][Full Text] [Related]
13. Cardiac repolarization: insights from mathematical modeling and electrocardiographic imaging (ECGI).
Rudy Y
Heart Rhythm; 2009 Nov; 6(11 Suppl):S49-55. PubMed ID: 19880074
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific ablation of synapse-associated protein SAP97 in mice decreases potassium currents but not sodium current.
Gillet L; Rougier JS; Shy D; Sonntag S; Mougenot N; Essers M; Shmerling D; Balse E; Hatem SN; Abriel H
Heart Rhythm; 2015 Jan; 12(1):181-92. PubMed ID: 25447080
[TBL] [Abstract][Full Text] [Related]
15. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
Grunnet M
Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
[TBL] [Abstract][Full Text] [Related]
16. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol on cardiac ion channel currents.
Möller C; Netzer R
Eur J Pharmacol; 2006 Feb; 532(1-2):44-9. PubMed ID: 16480714
[TBL] [Abstract][Full Text] [Related]
18. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data.
Jonker DM; Kenna LA; Leishman D; Wallis R; Milligan PA; Jonsson EN
Clin Pharmacol Ther; 2005 Jun; 77(6):572-82. PubMed ID: 15961988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
